Register entry
- Registered sites
- 11
- Active NDC listings
- 29
- Live patents
- 0
- Countries
- 6
- Base
- United States
Authorisation
Registered operations
Analytical testing8Active ingredient (API) manufacture6Labelling8Finished drug manufacture7Packaging9particle size reduction1Relabelling4Repackaging4sterilize3
Sites
Registered establishments
11| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Jurox Pty. LimitedRegistrant: Zoetis Inc | 85 Gardiner Street, Rutherford, NSW 2320, Australia (AUS) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, sterilize | 3003483729751438037 |
| Zoetis Belgium S.A.Registrant: Zoetis Inc | Rue Laid Burniat 1, Ottignies-Louvain-la-Neuve, Louvain-la-Neuve B1348, Belgium (BEL) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, sterilize | 3010087842370053142 |
| Zoetis Manufacturing & Research Spain, S.L.Registrant: Zoetis Inc | Carretera de Camprodon (L'hostal nou de Bianya), La Vall De, Bianya, Gerona 17813, Spain (ESP) | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3001748505460052343 |
| ZOETIS BELGIUM S.ARegistrant: Zoetis Inc | The Copse, RATHDRUM, , Ireland (IRL) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture, particle size reduction | 3015422006986062452 |
| Zoetis Belgium S.a.Registrant: Zoetis Inc | Sragh Technology Park, Tullamore, Co. Offaly , Ireland (IRL) | Analytical testing, Active ingredient (API) manufacture, Finished drug manufacture | 3015596301986062582 |
| Zoetis Manufacturing Italia SRLRegistrant: Zoetis Inc | Via Gorgone Franco S.N.C., CATANIA, 95121, Italy (ITA) | Analytical testing, Active ingredient (API) manufacture, Packaging | 3010097713339697390 |
| ZOETIS INC.Registrant: Zoetis Inc | 200 S GEOSPACE DR, INDEPENDENCE, Missouri (MO) 64056-3338, United States (USA) | Labelling, Packaging, Relabelling, Repackaging | 3007919064079767221 |
| Zoetis LLCRegistrant: Zoetis Inc | 2605 E. Kilgore Road, Kalamazoo, Michigan (MI) 49001, United States (USA) | Analytical testing, Labelling, Finished drug manufacture, Packaging, Relabelling, Repackaging | 3010146372079995959 |
| ZOETISRegistrant: Zoetis Inc | 1 Se Pfizer Way, Lees Summit, Missouri (MO) 64081, United States (USA) | Labelling, Packaging, Relabelling, Repackaging | 1922097071419364 |
| Zoetis Services LLCRegistrant: Zoetis Inc | 1100 NW Main St, Lees Summit, Missouri (MO) 64086, United States (USA) | Labelling, Packaging, Relabelling, Repackaging | 3030978447119241673 |
| Zoetis LLCRegistrant: Zoetis Inc | 601 West Cornhusker Highway, Lincoln, Nebraska (NE) 68521-3577, United States (USA) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 1910179039055157 |
Catalogue
Drug listings by form and route
2929 active NDC listings: 24 drug for further processing, 5 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 19, BULK INGREDIENT 5, EXPORT ONLY 5.
| Dosage form | NDCs |
|---|---|
| tablet, chewable | 15 |
| powder | 4 |
| tablet | 3 |
| tablet, coated | 3 |
| solution | 2 |
| liquid | 1 |
| paste | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| zoetis inc. | 29 |
Catalogue
Marketed products
29| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Bedinvetmab | solution | 54771-2782BULK INGREDIENT |
| - | Doramectin | powder | 54771-0207BULK INGREDIENT |
| - | Doxycycline | paste | 54771-5246EXPORT ONLY |
| - | Malic Acid, Benzoic Acid, Salicylic Acid | solution | 54771-7600DRUG FOR FURTHER PROCESSING |
| - | Moxidectin | powder | 54771-7016BULK INGREDIENT |
| - | Nutritional Supplement | tablet | 54771-8446EXPORT ONLY |
| - | Nutritional Supplement | tablet | 54771-8448EXPORT ONLY |
| - | Nutritional Supplement | tablet | 54771-8451EXPORT ONLY |
| - | Oclacitinib maleate | tablet, coated | 54771-0495DRUG FOR FURTHER PROCESSING |
| - | Oclacitinib maleate | tablet, coated | 54771-0496DRUG FOR FURTHER PROCESSING |
| - | Oclacitinib maleate | tablet, coated | 54771-0497DRUG FOR FURTHER PROCESSING |
| - | Oclacitinib maleate | tablet, chewable | 54771-1207DRUG FOR FURTHER PROCESSING |
| - | Oclacitinib maleate | tablet, chewable | 54771-1208DRUG FOR FURTHER PROCESSING |
| - | Oclacitinib maleate | tablet, chewable | 54771-1209DRUG FOR FURTHER PROCESSING |
| - | Oclacitinib maleate | powder | 54771-1344BULK INGREDIENT |
| - | sarolaner | tablet, chewable | 54771-1371DRUG FOR FURTHER PROCESSING |
| - | sarolaner | tablet, chewable | 54771-1372DRUG FOR FURTHER PROCESSING |
| - | sarolaner | tablet, chewable | 54771-1373DRUG FOR FURTHER PROCESSING |
| - | sarolaner | tablet, chewable | 54771-1374DRUG FOR FURTHER PROCESSING |
| - | sarolaner | tablet, chewable | 54771-1375DRUG FOR FURTHER PROCESSING |
| - | sarolaner | tablet, chewable | 54771-1376DRUG FOR FURTHER PROCESSING |
| - | sarolaner | powder | 54771-2716BULK INGREDIENT |
| - | sarolaner, moxidectin, and pyrantel | tablet, chewable | 54771-2667DRUG FOR FURTHER PROCESSING |
| - | sarolaner, moxidectin, and pyrantel | tablet, chewable | 54771-2668DRUG FOR FURTHER PROCESSING |
| - | sarolaner, moxidectin, and pyrantel | tablet, chewable | 54771-2669DRUG FOR FURTHER PROCESSING |
| - | sarolaner, moxidectin, and pyrantel | tablet, chewable | 54771-2670DRUG FOR FURTHER PROCESSING |
| - | sarolaner, moxidectin, and pyrantel | tablet, chewable | 54771-2671DRUG FOR FURTHER PROCESSING |
| - | sarolaner, moxidectin, and pyrantel | tablet, chewable | 54771-2684DRUG FOR FURTHER PROCESSING |
| - | vitamins | liquid | 54771-8443EXPORT ONLY |
Neighbours
Registered in the same town
5- Excite Pharma Services, LLCLEES SUMMIT, MO; Lees Summit, MO · 2 sites
- Pfizer IncKalamazoo, MI
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.Catania, ITA
- Haleon US Holdings LLCLincoln, NE
- Dipharma Francis SrlKalamazoo, MI
Compare
Comparable companies in United States
- The Procter & Gamble Manufacturing Company11 sites · 849 NDC
- Pfizer Inc11 sites · 27 NDC
- Sotera Health LLC11 sites · 2 NDC
- Eli Lilly and Company10 sites · 189 NDC
- Siegfried USA, LLC12 sites · 54 NDC
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.10 sites · 30 NDC
- Medical-technical Gases, Inc.10 sites · 7 NDC
- SOFIE Co. dba SOFIE12 sites · 5 NDC
- Alcami Carolinas Corporation10 sites · 1 NDC
- AbbVie Inc.13 sites · 131 NDC
Enquiry
Common questions
- Is Zoetis Inc FDA approved?
- Zoetis Inc holds 11 FDA-registered establishments across 6 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Zoetis Inc's drugs manufactured?
- At registered sites in Australia, Belgium, Spain, Ireland, Italy, the United States. The FDA register lists Rutherford; Ottignies-Louvain-la-Neuve; Bianya; The Copse; Tullamore; CATANIA, and 4 more. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, particle size reduction, relabelling, repackaging, sterilize.
- What drugs does Zoetis Inc make?
- 29 products are listed under Zoetis Inc in the openFDA NDC Directory, most often as tablet, chewable; powder; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.